HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.

Abstract
Ornithine-delta-aminotransferase (OAT) (EC 2.6.1.13) is a pyridoxal-5' phosphate dependent mitochondrial matrix enzyme. It controls the L-ornithine (Orn) level in tissues by catalysing the transfer of the delta-amino group of Orn to 2-oxoglutarate. The products of this reaction are L-glutamate-gamma-semialdehyde and L-glutamate. Among the compounds known to inhibit (or inactivate) OAT, only L-canaline and (SS)-5-(fluoromethyl)ornithine [(SS)-5FMOrn] are selective for OAT. Treatment of laboratory animals with 5FMOrn causes a dramatic accumulation of Orn in most tissues and organs, and the enhanced formation of urea due to saturation of ornithine:carbamoyltransferase with its substrate. The enhancement of urea formation by increased endogenous levels of Orn is comparable with that produced by large doses of Orn and arginine, a treatment known to enhance the detoxification of ammonia. However, protection to lethal doses of ammonium salts by exogenous Orn is rapidly fading. In contrast, inactivation of OAT by a small dose of 5FMOrn renders a long-lasting protective effect against various forms of hyperammonemic states. Among these the reduction of ammonia concentrations in blood and tissues, and the reduction of the pathologic excretion of orotic acid to normal levels in mice with hereditary defects of the urea cycle, were most impressive. In human hereditary OAT deficiency the elevated intraocular concentrations of Orn are considered to be a cause of gyrate atrophy. This is presumably the reason, why OAT has not been considered as a therapeutically useful target. Chronic inactivation of OAT by repeated administration of 5FMOrn, caused elevated intraocular Orn concentrations, but this treatment had no effect on the function and histology of the visual system, or the behaviour of adult mice. The confirmation of this and related observations in higher species will show, whether OAT inactivation has potentials in the treatment of hyperammonemic states.
AuthorsN Seiler
JournalCurrent drug targets (Curr Drug Targets) Vol. 1 Issue 2 Pg. 119-53 (Sep 2000) ISSN: 1389-4501 [Print] United Arab Emirates
PMID11465067 (Publication Type: Journal Article, Review)
Chemical References
  • Biogenic Polyamines
  • Enzyme Inhibitors
  • Thioacetamide
  • 5-fluoromethylornithine
  • Ammonia
  • Urea
  • Ornithine
  • Ornithine-Oxo-Acid Transaminase
Topics
  • Ammonia (metabolism)
  • Animals
  • Biogenic Polyamines (metabolism)
  • Brain (drug effects, enzymology)
  • Chorioretinitis (chemically induced, metabolism)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Humans
  • Hyperammonemia (drug therapy, metabolism)
  • Kidney (drug effects, enzymology)
  • Liver (drug effects, enzymology)
  • Mice
  • Ornithine (analogs & derivatives, drug effects, metabolism, pharmacology, therapeutic use)
  • Ornithine-Oxo-Acid Transaminase (antagonists & inhibitors, drug effects, metabolism)
  • Thioacetamide (pharmacology)
  • Urea (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: